Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis

por Worm, Margitta, Pfaar, Oliver
Publicado 2023

Placebo effects in allergen immunotherapy: an experts’ opinion

por Frew, Anthony J., Pfaar, Oliver
Publicado 2018

7 Comparison of Efficacy and Safety of a Dipigmented Polymerized Allergen Extract of Grass and Birch with Placebo in Patients With Type-1 Allergic Rhinoconjunctivitis

por Sager, Angelika, Biedermann, Tilo, Pfaar, Oliver
Publicado 2012

10 Seasonal Versus Symptom-based Evaluation of a Depigmented Grass-Birch Allergoid

por Pfaar, Oliver, Biedermann, Tilo, Sager, Angelika
Publicado 2012

Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?

por Pfaar, Oliver, Gerth van Wijk, Roy
Publicado 2015

Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients

por Pfaar, Oliver, Sager, Angelika, Robinson, Douglas S
Publicado 2015

Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps

por Sousa-Pinto, Bernardo, Pfaar, Oliver, Bousquet, Jean
Publicado 2023

Clinical endpoints in allergen immunotherapy: State of the art 2022

por Gerth van Wijk, Roy, Klimek, Ludger, Pfaar, Oliver
Publicado 2023

A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio

por Pfaar, Oliver, Sager, Angelika, Mösges, Ralph, Worm, Margitta
Publicado 2023

AIT und Covid-19 - Empfehlung von DGAKI und AeDA

por Worm, Margitta, Pfaar, Oliver, Klimek, Ludger, Brehler, Randolf
Publicado 2020

Digital health for allergen immunotherapy

por Dramburg, Stephanie, Matricardi, Paolo Maria, Pfaar, Oliver, Klimek, Ludger
Publicado 2022

Therapie der chronischen Rhinosinusitis mit Polyposis nasi (CRScNP) mit monoklonalen Antikörpern (Biologika): S2k-Leitlinie der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkund...

por Pfaar, Oliver, Beule, Achim Georg, Laudien, Martin, Stuck, Boris A.
Publicado 2023

Management of the polyallergic patient with allergy immunotherapy: a practice-based approach

por Demoly, Pascal, Passalacqua, Giovanni, Pfaar, Oliver, Sastre, Joaquin, Wahn, Ulrich
Publicado 2016

Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence

por Demoly, Pascal, Passalacqua, Giovanni, Pfaar, Oliver, Sastre, Joaquin, Wahn, Ulrich
Publicado 2016

Adherence in allergen immunotherapy: Current situation and future implications

por Gehrt, Francesca, Xu, Qingqing, Baiardini, Ilaria, Canonica, Giorgio Walter, Pfaar, Oliver
Publicado 2022

111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases

por Gutermuth, Jan, Grosber, Martine, Pfaar, Oliver, Bergmann, Karl Christian, Ring, Johannes
Publicado 2022

Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis

por Pfaar, Oliver, Richter, Hartmut, Sager, Angelika, Miller, Christoph, Müller, Thomas, Jutel, Marek
Publicado 2023

The placebo effect in allergen-specific immunotherapy trials

por Narkus, Annemie, Lehnigk, Ulrike, Haefner, Dietrich, Klinger, Regine, Pfaar, Oliver, Worm, Margitta
Publicado 2013

Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany

por Brehler, Randolf, Klimek, Ludger, Vogelberg, Christian, Werfel, Thomas, Pfaar, Oliver, Hamelmann, Eckard
Publicado 2016

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adole...

por Novak, Natalija, Worm, Margitta, Staubach, Petra, Jutel, Marek, Sager, Angelika, Pfaar, Oliver
Publicado 2022